After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Geron (GERN) announced on Monday that it agreed to a licensing deal with Janssen Pharmaceuticals worth $80 million.
Trade-Ideas LLC identified Geron (GERN) as a strong on high relative volume candidate
Trade-Ideas LLC identified Geron (GERN) as a weak on high relative volume candidate
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.